Cargando…
Mirogabalin—A Novel Selective Ligand for the α2δ Calcium Channel Subunit
The efficacy of neuropathic pain control remains unsatisfactory. Despite the availability of a variety of therapies, a significant proportion of patients suffer from poorly controlled pain of this kind. Consequently, new drugs and treatments are still being sought to remedy the situation. One such n...
Autores principales: | Zajączkowska, Renata, Mika, Joanna, Leppert, Wojciech, Kocot-Kępska, Magdalena, Malec-Milewska, Małgorzata, Wordliczek, Jerzy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911728/ https://www.ncbi.nlm.nih.gov/pubmed/33572689 http://dx.doi.org/10.3390/ph14020112 |
Ejemplares similares
-
Bone Pain in Cancer Patients: Mechanisms and Current Treatment
por: Zajączkowska, Renata, et al.
Publicado: (2019) -
Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain
por: Zajączkowska, Renata, et al.
Publicado: (2022) -
Transdermal and Topical Drug Administration in the Treatment of Pain
por: Leppert, Wojciech, et al.
Publicado: (2018) -
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019) -
Perioperative Immunosuppression and Risk of Cancer Progression: The Impact of Opioids on Pain Management
por: Zajączkowska, Renata, et al.
Publicado: (2018)